Home Top Movers Solid Biosciences Inc. (SLDB) Stock Skyrockets as Latest Target of Reddit-Driven Short...

Solid Biosciences Inc. (SLDB) Stock Skyrockets as Latest Target of Reddit-Driven Short Squeeze of Meme Stocks

Solid Biosciences Inc. (SLDB) stock prices were up by 2.91% as of the market closing on June 8th, 2021, bringing the price per share up to USD$4.06 at the end of the trading day. Subsequent current market fluctuations have seen the stock soar by 3.20%, bringing it up to USD$4.19.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Meme Stock Phenomenon

In the absence of significant recent news or changes in fundamentals, SLDB’s fortuitous surge in the value of its equity is largely attributable to the growing meme stock phenomenon that has taken over the market.  As users of the social media platform, Reddit, collaborate and target underdog companies with high short interests to artificially drive the prices up, retail investors profit while corporate investors scramble to mitigate drastic losses.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Collaboration Revenue Report

Collaboration revenue was reported at USD$3.3 million for the first quarter of the fiscal year 2021, up from no collaboration revenue being reported for the same time period of the year prior. The year-over-year increase is largely attributable to an increase in collaboration revenue related to research services and the reimbursement of expenses from the Collaboration Agreement with Ultragenyx.

R&D Expenses

Research and Development costs were down to USD$14.2 million in the first quarter of fiscal 2021 from the USD$19.7 million reported in the year-ago quarter. This difference is largely attributable to the lower expenses related to SGT-001, the company’s lead product candidate. This was driven by a reduction in manufacturing expenses, clinical costs, and unallocated R&D costs.

G&A Costs

General and administrative costs were up from USD$5.3 million in the first quarter of the previous fiscal year to USD$6 million reported for Q1 2021. This year-over-year difference is largely attributable to the increased workforce cost that resulted from the company’s progression of its IGNITE DMD clinical trial. Net loss was reported at USD$16.9 million for Q1 2021, with Q1 2020 having reported USD$26.7 million.

Solid Liquidity Position

The company reported having cash and cash equivalents in the amount of USD$268.5 million as of March 31st, 2021. USD$143.8 million of their total liquidity position was generated through its underwritten public offering earlier in the first quarter of the fiscal year 2021. This stellar liquidity position supports the company’s forecast of being able to fund its operating expenses and capital expenditures through to the fourth quarter of the fiscal year 2022.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for SLDB

Armed with the inflated value of its equity, SLDB is poised to capitalize on this fortuitous opportunity to situate itself for a post-pandemic economy. The company is keen to continue its trajectory of success and use the springboard of the meme stock craze to usher in more organic growth over the future. Current and potential investors are hopeful that management will leverage the resources at their disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam